Team
Headquartered in Stockholm, we are a team of senior biotech and life science venture capital executives with vast experience in developing, launching, and commercializing rare disease and specialty care products. Our capabilities include regulatory affairs, market access, medical affairs, sales and marketing, quality assurance, and pharmacovigilance.
Jonas Hansson
MSc Pharm, MBA
CEO
Jonas is a co-founder of Purpose Pharma. >20 years of industry experience. Most recently, Jonas was a partner with HealthCap, a life science focused VC. Jonas was a co-founder and the CEO or Wilson Therapeutics (acquired by Alexion for $855m).
Jacob Gunterberg
MSc BA & Economics
CFO
Jacob is a co-founder of Purpose Pharma. >25 years of experience from in life sciences venture capital investing and investment banking. Most recently, Jacob was a partner with HealthCap, a leading life science focused VC.
Lars Olsson
PhD Organic Chemistry
COO
Lars is a co-founder of Purpose Pharma. >20 years of experience from the industry. Most recently, Lars was responsible for CMC at Guard Therapeutics. Previous engagements include positions with Wilson Therapeutics (acquired by Alexion for $855m), Karo Bio and AZN.
Adam Karlsson
MBBS/BSc Pharm, MPhil
Head of Business Development
Adam is a former Pharma Analyst and Head of Healthcare Equity Research at ABG Sundal Collier. Prior to this, Adam practiced as a physician at University College Hospital London. Adam received his medical degree and a BSc in Pharmacology from Imperial College London, and an MPhil in Bioscience Enterprise from Queens’ College, Cambridge.
Dr. Thirusha Lane
MSc, PhD
Head of Medical Affairs
Thirusha has nearly thirty years’ healthcare and academia experience and with a PhD in Amyloidosis. Among others, Thirusha has worked as Lead Nurse & Head of Clinical Trials Operations at the UK National Amyloidosis Centre and most recently as part of the global Medical Affairs & Patient Advocacy team at Alnylam Pharmaceuticals. Author/co-author of over 50 peer-reviewed publications in the fields of amyloidosis, rare autoinflammatory conditions and multiple sclerosis.
Filipe Assoreira
MSc Pharm, MBA
Head of Commercial
Filipe is a life science executive with deep international experience in operations, P&L oversight, multichannel product distribution and marketing both in start-up and growth organizations, including as Country Manager for Genzyme.
Steve Pinder
PhD Molecular Genetics
Head of Regulatory Affairs
Steve qualified in biochemistry before completing a PhD and post-doctoral work in molecular genetics. Steve has >30 years of regulatory experience from the life science industry focusing on clinical drug development and regulatory strategy.
Kerstin Annas
MsC Chemistry
Quality Manager
Kerstin has more than 20 years experience in the pharma industry as QA manager, QP, RP and auditor from companies like Fresenius Kabi, Moberg Pharma and Pharmarelations.
Emil Gidlund
Business, MSc Economics & Languages
Head of Unlicensed
Emil is a former Group Category Manager Rx and Rx Purchase Manager with Kronans Apotek (one of Sweden’s largest pharmacy chains and part of Oriola). Emil has also been responsible for the unlicensed medicines business with Kronans Apotek.